Evidence map›Paper›PMID 31117965›Full record

ArticleBMC cancer2019

Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.

Nyasia M Jones, Hua Yang, Qing Zhang, Vanessa M Morales-Tirado, Hans E Grossniklaus

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Animal Models of Uveal Melanoma.Annals of eye science · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nyasia M JonesGraduate Division of Biological and Biomedical Sciences Cancer Biology and Translational Oncology, Emory University, Atlanta, GA, 30322, USA.
Hua YangDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Qing ZhangDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Vanessa M Morales-TiradoDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Hans E GrossniklausDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, 30322, USA. ophtheg@emory.edu.
Emory University · USUniversity of Tennessee Health Science Center · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma MetastasisR01CA176001 · NCI · EMORY UNIVERSITY · PI GROSSNIKLAUS, HANS E., VAN MEIR, ERWIN G. · 2014 to 2018
$1.7M
Foundation for the National Institutes of Health NIH P30EY06360National Institutes of Health NIH R01CA176001NCI NIH HHS R01 CA176001NEI NIH HHS P30 EY006360
6 · The paper itself

Abstract

backgroundMetastases account for 90% of all cancer-related deaths, becoming a therapeutic problem. Approximately 50% of all uveal melanoma (UM) patients will develop metastases, mainly in the liver. Post-mortem analyses of livers from metastatic UM patients showed two different metastatic growth patterns: infiltrative and nodular. The infiltrative pattern exhibits tumor infiltration directly to the hepatic lobule and minimal angiogenesis. The nodular pattern shows clusters of tumor cells around the portal venules that efface the liver parenchyma. We recently demonstrated Natural Killer (NK) cells play a pivotal role in the control of hepatic metastases and the pigment epithelial-derived factor (PEDF) controls angiogenesis in the liver using our established ocular melanoma animal model. In this study we investigated the role of NK cells and PEDF in the development of metastatic growth patterns, as this can contribute to the development of novel therapeutics specific towards each growth pattern.

methodsWe utilize our established ocular melanoma animal model by inoculation of B16-LS9 melanoma cells into C57BL/6 J mice (WT), anti-asialo GM1-treated C57BL/6 J mice (NK-depleted), and PEDF

resultsOur in vivo work showed two distinct metastatic growth patterns, the infiltrative and nodular, recapitulating the post-mortem analyses on human liver tissue. We discovered NK cells control the infiltrative growth. In contrast, PEDF controlled anti-angiogenic responses, showing higher MVD values compared to NK-depleted and WT animals. The myeloid lineage, comprised of monocytes, macrophages, and myeloid-derived suppressor cells, was reduced in the absence of NK cells or PEDF.

conclusionsOur animal model recapitulates the metastatic growth patterns observed in the human disease. We demonstrated a role for NK cells in the development of the infiltrative growth pattern, and a role for PEDF in the development of the nodular pattern. The understanding of the complexity associated with the metastatic progression has profound clinical implications in the diagnostic and disease-management as we can develop and direct more effective therapies.

Indexed as

AnimalsAntibodiesCell Line, TumorEye ProteinsFemaleGene Knockout TechniquesG(M1) GangliosideKiller Cells, NaturalLiver NeoplasmsMacrophagesMelanomaMiceMice, Inbred C57BLMonocytesMyeloid-Derived Suppressor CellsNeoplasm TransplantationAntibodiesasialo GM1 gangliosideEye ProteinsG(M1) GangliosideNerve Growth FactorsPigment Epithelium-Derived FactorSerpinsAnimal modelsHepatic metastasesNK cellsOcular melanomaPEDFTumor dissemination

Identifiers

PMID31117965
PMCPMC6532210
OpenAlexW2946879465

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.